Disruption of p53 in Human Cancer Cells Alters the Responses to Therapeutic Agents

Case ID:

C03920

C03920: Disruption of p53 in Human Cancer Cells Alters the Responses to Therapeutic Agents
Technical Details:
p53 knockout in human colorectal cancer cell line HCT116. Details are described in the paper by Bunz et al., 1999
Looking for Partners:
The p53 gene is inactivated in the majority of human cancers. JHU scientists determined that p53 knockout cell lines have altered responses to therapeutic agents, being sensitized to DNA damaging agents but resistant to anti-metabolite 5-fluorouracil. This novel knock-out line provides the basis for a new drug screen to identify compounds that specifically kill cells with p53 mutations.

Direct Link:

https://jhu.technologypublisher.com/technology/16221

Inventors:

Category(s):

Clinical and Disease Specializations, Clinical and Disease Specializations > Gastroenterology, Clinical and Disease Specializations > Oncology > Colorectal Cancer, Technology Classifications > Research Tools > Cell Lines, Clinical and Disease Specializations > Oncology, Technology Classifications > Research Tools,

Get custom alerts for techs in these categories/from these inventors:

Subscribe for JHTV Updates

For Information, Contact:

Jeanine Pennington

jpennin5@jhmi.edu

410-614-0300

Save This Technology:

Bookmark this page

Download as PDF